Curated News
By: NewsRamp Editorial Staff
June 06, 2025
INBS Showcases Rapid Fingerprint Drug Screening at RISE25
TLDR
- Intelligent Bio Solutions' rapid drug screening system offers a competitive edge by enabling quick, on-site decisions in justice and healthcare sectors.
- The system analyzes fingerprint sweat for drugs, delivering results in under ten minutes, streamlining the screening process for efficiency and accuracy.
- This technology enhances public safety and health by providing a non-invasive method to detect drug use, supporting recovery and justice efforts.
- Discover how a simple fingerprint can reveal drug use in minutes, revolutionizing drug testing with Intelligent Bio Solutions' innovative approach.
Impact - Why it Matters
The introduction of INBS's portable, non-invasive drug screening system represents a significant advancement in drug testing technology. Its ability to provide rapid results on-site can revolutionize decision-making in treatment and justice settings, offering a quicker, less intrusive alternative to traditional methods. This innovation not only enhances efficiency but also opens new avenues for addressing substance abuse and ensuring workplace safety, making it a critical development for healthcare providers, law enforcement, and employers alike.
Summary
Intelligent Bio Solutions (NASDAQ: INBS), a pioneering medical technology company, recently showcased its innovative Intelligent Fingerprint Drug Screening System at the RISE25 conference in Florida. This non-invasive system utilizes fingerprint sweat to detect substances like cannabis, cocaine, methamphetamine, and opiates, delivering results in under ten minutes. With over 450 active accounts across 24 countries, INBS is making significant strides in healthcare, justice, and workplace safety sectors. The company's partnership with SMARTOX aims to strengthen its presence in the U.S. market, particularly in criminal justice and addiction recovery. Currently operating under Forensic Use Only in the U.S., INBS is actively pursuing FDA approval to expand its reach. The RISE25 conference, attended by more than 7,000 professionals, served as a pivotal platform for INBS to demonstrate its portable drug testing solution and engage with key stakeholders in the industry.
For those interested in the latest developments from INBS, updates are available in the company’s newsroom. BioMedWire, a specialized communications platform, provides comprehensive coverage on INBS and other innovations in the Biotechnology and Life Sciences sectors, ensuring stakeholders stay informed about groundbreaking technologies and market expansions.
Source Statement
This curated news summary relied on content disributed by InvestorBrandNetwork (IBN). Read the original source here, INBS Showcases Rapid Fingerprint Drug Screening at RISE25
